BY
Bai, Yuxian
2 papers · 431 citations · 2023–2024
Publications
2
Citations
431
Years
2
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Pembrolizumab in HER2-Positive Gastric Cancer
|
2024 | Letter | 47 |
|
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
|
2023 | Article | 384 |